[Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer]
- PMID: 18176375
- DOI: 10.1016/s0399-8320(07)78353-7
[Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer]
Abstract
Pancreatic adenocarcinoma is the fifth most common cause of cancer-related mortality in the world. The nucleoside analogue gemcitabine is the established standard therapy for advanced disease. Rare cases of gemcitabine-associated systemic capillary leak syndrome have been reported. Here, we present two cases of capillary-leak syndrome in patients with pancreatic cancer treated with gemcitabine.
Similar articles
-
Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease.Clin Oncol (R Coll Radiol). 2004 Dec;16(8):577-9. doi: 10.1016/j.clon.2004.06.019. Clin Oncol (R Coll Radiol). 2004. PMID: 15630853
-
Gemcitabine-induced chronic systemic capillary leak syndrome.BMJ Case Rep. 2017 Aug 30;2017:bcr2017221068. doi: 10.1136/bcr-2017-221068. BMJ Case Rep. 2017. PMID: 28855215 Free PMC article.
-
Gemcitabine-induced severe extremity edema with muscle contractures and subsequent prevention with prednisone.Isr Med Assoc J. 2000 Jul;2(7):552-3. Isr Med Assoc J. 2000. PMID: 10979335 No abstract available.
-
Treatment of metastatic pancreatic cancer.J Natl Compr Canc Netw. 2005 Sep;3(5):627-36. doi: 10.6004/jnccn.2005.0036. J Natl Compr Canc Netw. 2005. PMID: 16194454 Review.
-
[Medical-oncological aspects in the treatment of pancreatic cancer].Radiologe. 2009 Feb;49(2):144-8. doi: 10.1007/s00117-008-1753-3. Radiologe. 2009. PMID: 19048221 Review. German.
Cited by
-
Anticancer Drug-Induced Capillary Leak Syndrome.Kidney Int Rep. 2022 Feb 25;7(5):945-953. doi: 10.1016/j.ekir.2022.02.014. eCollection 2022 May. Kidney Int Rep. 2022. PMID: 35570987 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical